Albert Einstein Cancer Center awarded NIH grant

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE ALBERT EINSTEIN CANCER CENTER and the Montefiore Einstein Center for Cancer Care received a Ruth L. Kirschstein NRSA Institutional Research Training Grant from NIH, which will provide $1.18 million in funding over five years.

This new competitive program is designed so that surgical residents in training spend two additional years in hands-on training as research fellows focused on the study of malignant tumors, the role of the immune system in tumor growth inhibition and the identification of emerging novel targets.

The 15 faculty members guiding this training, both as educators and mentors, represent six clinical and four basic science departments. Participating research fellows are expected to submit at least two abstracts to national meetings and at least one original manuscript for peer review by the completion of their training.

Table of Contents

YOU MAY BE INTERESTED IN

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login